Skip to main content
OpenTrials

Clinical trial condition

Solid Tumors

Explore clinical trials studying Solid Tumors. Study availability and eligibility vary by location and protocol.

582 public trials 81 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumors trial results

Completed

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

NCT02903914

Conditions
Adenocarcinoma, Adenoma, Bladder Cancer, +49 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • Honor Health/Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • Georgetown Washington D.C., District of Columbia, United States
View all 20 locations
View Trial Details
Completed

Phase 1 Open-label Study of TRX518 Monotherapy and TRX518 in Combination With Gemcitabine, Pembrolizumab, or Nivolumab

NCT02628574

Conditions
Disease Attributes, Neoplasm Metastasis, Neoplasms, +5 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • University Hospitals Cleveland, Ohio, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b

NCT02279433

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +23 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Chao Family Comprehensive Cancer Center of Orange, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Inst. Boston, Massachusetts, United States
View Trial Details
Completed

A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

NCT02632448

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +55 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
View all 16 locations
View Trial Details
Completed

A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors

NCT03954067

Conditions
Advanced Cancer, DNA Virus Infections, Infections, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arizona - Arizona Cancer Center Tucson, Arizona, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
View all 17 locations
View Trial Details
Completed

A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors

NCT04704154

Conditions
Astrocytoma, Carcinoma, Carcinoma, Squamous Cell, +21 more
Locations
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Rocky Mountain Cancer Centers / Aurora, CO Aurora, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Sarah Cannon Cancer Center Nashville, Tennessee, United States
View all 34 locations
View Trial Details
Completed

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

NCT04774952

Conditions
Adnexal Diseases, Bronchial Diseases, Bronchial Neoplasms, +63 more
Locations
  • UC Irvine - Chao Family Comprehensive Cancer Center Irvine, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Francisco - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details

Related conditions